Coordinatore | UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT 13 contact info |
Nazionalità Coordinatore | Belgium [BE] |
Totale costo | 31˙379˙377 € |
EC contributo | 23˙992˙375 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2013-INNOVATION-1 |
Funding Scheme | CP-IP |
Anno di inizio | 2014 |
Periodo (anno-mese-giorno) | 2014-02-01 - 2019-01-31 |
# | ||||
---|---|---|---|---|
1 |
UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT 13 contact info |
BE (ANTWERPEN) | coordinator | 3˙505˙368.00 |
2 |
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Organization address
address: HEIDELBERGLAAN 100 contact info |
NL (UTRECHT) | participant | 4˙006˙292.00 |
3 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 3˙307˙457.40 |
4 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 2˙102˙020.00 |
5 |
EUROPEAN SOCIETY OF INTENSIVE CARE MEDECINE
Organization address
address: RUE MICHELI DU CREST 24 contact info |
CH (GENEVE) | participant | 2˙100˙400.00 |
6 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 1˙426˙432.00 |
7 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 1˙015˙400.00 |
8 |
UNIVERSITAETSKLINIKUM BONN
Organization address
address: Sigmund-Freud-Strasse 25 contact info |
DE (BONN) | participant | 648˙300.00 |
9 |
FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS
Organization address
address: CORSO STATI UNITI 4 contact info |
IT (PADOVA) | participant | 633˙000.00 |
10 |
CAPNETZ STIFTUNG
Organization address
address: CARL NEUBERG STRASSE 1 contact info |
DE (HANNOVER) | participant | 506˙500.00 |
11 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Organization address
address: BELFIELD contact info |
IE (DUBLIN) | participant | 503˙674.40 |
12 |
BIOCARTIS NV
Organization address
address: GENERAAL DE WITTELAAN 11B contact info |
BE (MECHELEN) | participant | 486˙362.00 |
13 |
ROYAL BROMPTON AND HAREFIELD NATIONAL HEALTH SERVICE TRUST
Organization address
address: SYDNEY STREET contact info |
UK (LONDON) | participant | 408˙683.20 |
14 |
SERVIZO GALEGO DE SAUDE
Organization address
city: Santiago de Compostela contact info |
ES (Santiago de Compostela) | participant | 403˙600.00 |
15 |
HLA ET MEDECINE
Organization address
address: Avenue Claude Vellefaux 1 contact info |
FR (Paris) | participant | 377˙800.00 |
16 |
BIOMAX INFORMATICS AG
Organization address
address: ROBERT KOCH STRASSE 2 contact info |
DE (PLANEGG) | participant | 377˙788.00 |
17 |
CARDIFF UNIVERSITY
Organization address
address: Newport Road 30-36 contact info |
UK (CARDIFF) | participant | 356˙580.00 |
18 |
INSTITUT PASTEUR
Organization address
address: RUE DU DOCTEUR ROUX 25-28 contact info |
FR (PARIS CEDEX 15) | participant | 303˙264.00 |
19 |
EUROPEAN RESPIRATORY SOCIETY
Organization address
address: Avenue Sainte Luce 4 contact info |
CH (LAUSANNE) | participant | 284˙840.00 |
20 |
SVEUCILISTE U SPLITU (UNIVERSITY OF SPLIT)
Organization address
address: LIVANJSKA 5 contact info |
HR (SPLIT) | participant | 256˙200.00 |
21 |
BERRY CONSULTANTS LLP
Organization address
address: INTERNATIONAL HOUSE 124 CROMWELL ROAD contact info |
UK (LONDON) | participant | 240˙000.00 |
22 |
BIOMERIEUX SA
Organization address
address: Chemin de l'Orme contact info |
FR (Marcy l'Etoile) | participant | 210˙000.00 |
23 |
EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (EUROPAISCHE GESELLSCHAFT FUR KLINISCHE MIKROBIOLOGIE UND INFEKTIONSKRANKHEITEN)
Organization address
address: AESCHENVORSTADT 67 contact info |
CH (BASEL) | participant | 197˙600.00 |
24 |
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA
Organization address
address: TURNHOUTSEWEG 30 contact info |
BE (BEERSE) | participant | 194˙062.00 |
25 |
EUROPEAN SCIENTIFIC WORKING GROUP ON INFLUENZA
Organization address
address: ZEVENSTERSTRAAT 1 contact info |
BE (LAARNE) | participant | 80˙362.00 |
26 |
STICHTING WONCA EUROPE
Organization address
address: Mercatorlaan 1200 contact info |
NL (BL Utrecht) | participant | 60˙390.00 |
27 |
THE UNIVERSITY OF WESTERN AUSTRALIA
Organization address
address: Stirling Higway 35 contact info |
AU (CRAWLEY) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcare systems in the world, and also the world’s supreme researchers in this field, we lack co-ordination and linkage between networks that is required to respond fast to new threats. This consortium of consortia will streamline our response, using primary and secondary healthcare to detect cases with pandemic potential and to activate dynamic rapid investigation teams that will deploy shared resources across Europe to mitigate the impact of future pandemics on European health, infrastructure and economic integrity. If funded, PREPARE will transform Europe’s response to future severe epidemics or pandemics by providing infrastructure, co-ordination and integration of existing clinical research networks, both in community and hospital settings. It represents a new model of collaboration and will provide a one-stop shop for policy makers, public health agencies, regulators and funders of research into pathogens with epidemic potential. It will do this by mounting interepidemic (‘peace time’) patient oriented clinical trials in children and in adults, investigations of the pathogenesis of relevant infectious diseases and facilitate the development of sophisticated state-of-the-art near-patient diagnostics. We will develop pre-emptive solutions to ethical, administrative, regulatory and logistical bottlenecks that prevent a rapid response in the face of new threats. We will provide education and training not only to the members of the network, but also to external opinion leaders, funders and policy makers thereby streamlining our future response. By strengthening and integrating interepidemic research networks, PREPARE will enable the rapid coordinated deployment of Europe’s elite clinical investigators, resulting in a highly effective response to future outbreaks based on solid scientific advances.'
Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
Read MoreClinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD)
Read More